Clinical Trial Update: Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes. [Phase 3]

View source ↗

Summary

A Phase 3 trial compared insulin detemir with NPH insulin to evaluate efficacy and safety in subjects with type 1 diabetes. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin detemir (insulin detemir)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED